Clinical Trials Directory

Trials / Completed

CompletedNCT00313443

Concentrations of Amiodarone in Fat Tissue During Chronic Treatment

Study of Concentrations of Amiodarone in Fat Tissue Obtained by Needle Aspiration in Patients on Chronic Treatment

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Hopital Lariboisière · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to determine if concentrations of amiodarone in fat tissue increases constantly over time during chronic treatment with this drug, and if blood concentrations reflect accurately the concentrations in fat tissue or not. This is because excessive concentrations of this drug in tissues can produce adverse effects.

Detailed description

Amiodarone is very effective to treat cardiac arrhythmias but its use is limited by its toxicity, specially in chronic treatment. Accumulation of the drug in tissues is very probably the cause of the majority of amiodarone delayed adverse effects. However, this has not been proved because obtaining tissue samples is usually difficult and aggressive. The investigators study, in patients following chronic treatment with amiodarone, if needle aspiration can provide samples of fat tissue useful to accurately determine amiodarone concentrations, how those concentrations in fat tissue correlate with cumulated dose, and how concentrations in fat tissue correlate with concentrations in blood, which is easier to obtain. The investigators expect this knowledge will help to understand how amiodarone develops its adverse effects and possibly lead to new ways of monitoring treatment with this drug, or to adapt doses in chronic administration.

Conditions

Interventions

TypeNameDescription
PROCEDUREFat tissue needle aspirationSmall fat tissue sampling performed by needle aspiration.

Timeline

Start date
2006-04-01
Primary completion
2007-10-01
Completion
2007-10-01
First posted
2006-04-12
Last updated
2011-07-14
Results posted
2009-08-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00313443. Inclusion in this directory is not an endorsement.